Home › NDC Lookup › RxCUI directory › RxCUI 310430

Gabapentin 100 MG Oral Capsule — RxCUI 310430

RxNorm drug concept · Semantic clinical drug
RxCUI 310430 Semantic clinical drug · SCD ● Current RxNorm concept 218 FDA products 692 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI310430
Official nameGabapentin 100 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped218
Package NDCs mapped692
Reported Medicaid activity (SDUD)7,367,719 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Gabapentin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's used for nerve pain after shingles (postherpetic neuralgia). Many gabapentin products are also used as add-on treatment for partial seizures in epilepsy. Horizant is also used...
  • Dizziness and sleepiness are the most common side effects. Don't drive or use heavy machinery until you know how it affects you, because you may not judge your own impairment well.
  • Talk to your prescriber first. Stopping seizure medicines suddenly can increase seizures. Gralise should be changed or stopped gradually over at least a week.
  • Tell me about any opioid or sedating medicine, because together they can slow breathing dangerously. If you use an antacid like Maalox, take gabapentin at least 2 hours after it.
📖 Read our full Gabapentin guide →

🕸️ Concept Web — How Gabapentin 100 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Gabapentin 100 MG Oral Capsule RxCUI 310430

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Gabapentin 25480
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Neurontin 196498
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Gabapentin Oral Capsule 378100
    • Gabapentin Oral Product 1156681
    • Gabapentin Pill 1156682
    • Gabapentin Oral Capsule [Neurontin] 366770
    • Neurontin Oral Product 1182285
    • Neurontin Pill 1182286
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Gabapentin 100 MG SCDC · 345817
  • Gabapentin Oral Capsule SCDF · 378100
  • Gabapentin Oral Product SCDG · 1156681
  • Gabapentin Pill SCDG · 1156682

Brand-Name Concepts

  • Gabapentin 100 MG Oral Capsule [Neurontin] SBD · 105028
  • Gabapentin 100 MG [Neurontin] SBDC · 563877
  • Gabapentin Oral Capsule [Neurontin] SBDF · 366770
  • Neurontin Oral Product SBDG · 1182285
  • Neurontin Pill SBDG · 1182286
  • Neurontin BN · 196498

📦 FDA Products & Package NDCs

218 products · 692 package NDCs
692 package NDCs map to RxCUI 310430 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00071-0401-24 100 TABLET, FILM COATED in 1 BOTTLE (0071-0401-24) Neurontin Parke-Davis Div of Pfizer Inc 1998-10-09
00071-0803-24 100 CAPSULE in 1 BOTTLE (0071-0803-24) Neurontin Parke-Davis Div of Pfizer Inc 1993-12-30
00071-0805-24 100 CAPSULE in 1 BOTTLE (0071-0805-24) Neurontin Parke-Davis Div of Pfizer Inc 1993-12-30
00071-0806-24 100 CAPSULE in 1 BOTTLE (0071-0806-24) Neurontin Parke-Davis Div of Pfizer Inc 1993-12-30
00071-2012-47 1 BOTTLE, PLASTIC in 1 CARTON (0071-2012-47) / 470 mL in 1... Neurontin Parke-Davis Div of Pfizer Inc 2022-07-12
00904-6665-61 100 BLISTER PACK in 1 CARTON (0904-6665-61) / 1 CAPSULE in... Gabapentin Major Pharmaceuticals 2011-01-29
00904-6666-61 100 BLISTER PACK in 1 CARTON (0904-6666-61) / 1 CAPSULE in... Gabapentin Major Pharmaceuticals 2011-01-29
00904-6667-61 100 BLISTER PACK in 1 CARTON (0904-6667-61) / 1 CAPSULE in... Gabapentin Major Pharmaceuticals 2011-01-29
00904-7613-61 100 BLISTER PACK in 1 CARTON (0904-7613-61) / 1 CAPSULE in... Gabapentin Major Pharmaceuticals 2026-04-27
00904-7614-61 100 BLISTER PACK in 1 CARTON (0904-7614-61) / 1 CAPSULE in... Gabapentin Major Pharmaceuticals 2026-04-27
00904-7615-61 100 BLISTER PACK in 1 CARTON (0904-7615-61) / 1 CAPSULE in... Gabapentin Major Pharmaceuticals 2026-04-27
16571-0867-01 100 CAPSULE in 1 BOTTLE (16571-867-01) gabapentin Rising Pharma Holdings, Inc. 2022-08-01
16571-0867-03 30 CAPSULE in 1 BOTTLE (16571-867-03) gabapentin Rising Pharma Holdings, Inc. 2022-08-01
16571-0867-10 1000 CAPSULE in 1 BOTTLE (16571-867-10) gabapentin Rising Pharma Holdings, Inc. 2022-08-01
16571-0867-50 500 CAPSULE in 1 BOTTLE (16571-867-50) gabapentin Rising Pharma Holdings, Inc. 2022-08-01
16571-0868-01 100 CAPSULE in 1 BOTTLE (16571-868-01) gabapentin Rising Pharma Holdings, Inc. 2022-08-01
16571-0868-03 30 CAPSULE in 1 BOTTLE (16571-868-03) gabapentin Rising Pharma Holdings, Inc. 2022-08-01
16571-0868-10 1000 CAPSULE in 1 BOTTLE (16571-868-10) gabapentin Rising Pharma Holdings, Inc. 2022-08-01
16571-0868-50 500 CAPSULE in 1 BOTTLE (16571-868-50) gabapentin Rising Pharma Holdings, Inc. 2022-08-01
16571-0869-01 100 CAPSULE in 1 BOTTLE (16571-869-01) gabapentin Rising Pharma Holdings, Inc. 2022-08-01
16571-0869-03 30 CAPSULE in 1 BOTTLE (16571-869-03) gabapentin Rising Pharma Holdings, Inc. 2022-08-01
16571-0869-10 1000 CAPSULE in 1 BOTTLE (16571-869-10) gabapentin Rising Pharma Holdings, Inc. 2022-08-01
16571-0869-50 500 CAPSULE in 1 BOTTLE (16571-869-50) gabapentin Rising Pharma Holdings, Inc. 2022-08-01
16714-0661-01 100 CAPSULE in 1 BOTTLE (16714-661-01) Gabapentin NorthStar Rx LLC 2008-01-31
16714-0661-02 500 CAPSULE in 1 BOTTLE (16714-661-02) Gabapentin NorthStar Rx LLC 2008-01-31
16714-0661-03 1000 CAPSULE in 1 BOTTLE (16714-661-03) Gabapentin NorthStar Rx LLC 2008-01-31
16714-0662-01 100 CAPSULE in 1 BOTTLE (16714-662-01) Gabapentin NorthStar Rx LLC 2008-01-31
16714-0662-02 500 CAPSULE in 1 BOTTLE (16714-662-02) Gabapentin NorthStar Rx LLC 2008-01-31
16714-0662-03 1000 CAPSULE in 1 BOTTLE (16714-662-03) Gabapentin NorthStar Rx LLC 2008-01-31
16714-0663-01 100 CAPSULE in 1 BOTTLE (16714-663-01) Gabapentin NorthStar Rx LLC 2008-01-31
16714-0663-02 500 CAPSULE in 1 BOTTLE (16714-663-02) Gabapentin NorthStar Rx LLC 2008-01-31
23155-0866-01 100 CAPSULE in 1 BOTTLE (23155-866-01) GABAPENTIN Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2023-06-25
23155-0866-05 500 CAPSULE in 1 BOTTLE (23155-866-05) GABAPENTIN Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2023-06-25
23155-0867-01 100 CAPSULE in 1 BOTTLE (23155-867-01) GABAPENTIN Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2023-06-25
23155-0867-05 500 CAPSULE in 1 BOTTLE (23155-867-05) GABAPENTIN Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2023-06-25
23155-0868-01 100 CAPSULE in 1 BOTTLE (23155-868-01) GABAPENTIN Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2023-06-25
23155-0868-05 500 CAPSULE in 1 BOTTLE (23155-868-05) GABAPENTIN Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2023-06-25
25000-0103-03 30 CAPSULE in 1 BOTTLE (25000-103-03) GABAPENTIN MARKSANS PHARMA LIMITED 2011-02-28
25000-0103-12 500 CAPSULE in 1 BOTTLE (25000-103-12) GABAPENTIN MARKSANS PHARMA LIMITED 2011-02-28
25000-0103-14 1000 CAPSULE in 1 BOTTLE (25000-103-14) GABAPENTIN MARKSANS PHARMA LIMITED 2021-09-16
25000-0103-98 1 BAG in 1 BOX (25000-103-98) / 55555 CAPSULE in 1 BAG GABAPENTIN MARKSANS PHARMA LIMITED 2011-02-28
25000-0104-03 30 CAPSULE in 1 BOTTLE (25000-104-03) GABAPENTIN MARKSANS PHARMA LIMITED 2011-02-28
25000-0104-12 500 CAPSULE in 1 BOTTLE (25000-104-12) GABAPENTIN MARKSANS PHARMA LIMITED 2011-02-28
25000-0104-14 1000 CAPSULE in 1 BOTTLE (25000-104-14) GABAPENTIN MARKSANS PHARMA LIMITED 2021-09-16
25000-0105-03 30 CAPSULE in 1 BOTTLE (25000-105-03) GABAPENTIN MARKSANS PHARMA LIMITED 2011-02-28
25000-0105-12 500 CAPSULE in 1 BOTTLE (25000-105-12) GABAPENTIN MARKSANS PHARMA LIMITED 2011-02-28
25000-0105-14 1000 CAPSULE in 1 BOTTLE (25000-105-14) GABAPENTIN MARKSANS PHARMA LIMITED 2021-09-16
31722-0148-01 100 CAPSULE in 1 BOTTLE (31722-148-01) GABAPENTIN Camber Pharmaceuticals, Inc. 2021-05-10
31722-0148-05 500 CAPSULE in 1 BOTTLE (31722-148-05) GABAPENTIN Camber Pharmaceuticals, Inc. 2021-05-10
31722-0148-10 1000 CAPSULE in 1 BOTTLE (31722-148-10) GABAPENTIN Camber Pharmaceuticals, Inc. 2021-05-10
Observed labelers: Bryant Ranch Prepack (90) · Proficient Rx LP (52) · Asclemed USA, Inc. (46) · A-S Medication Solutions (30) · Laurus Labs Limited (30) · Preferred Pharmaceuticals Inc. (25) · +51 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.